222 related articles for article (PubMed ID: 9741666)
1. The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability.
Martínez M; Vayá A; Gil L; Martí R; Dalmau J; Aznar J
Clin Hemorheol Microcirc; 1998 Jul; 18(4):259-63. PubMed ID: 9741666
[TBL] [Abstract][Full Text] [Related]
2. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
3. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
Martínez M; Vayá A; Server R; Gilsanz A; Aznar J
Clin Hemorheol Microcirc; 1998 Jul; 18(4):253-8. PubMed ID: 9741665
[TBL] [Abstract][Full Text] [Related]
4. Plasma thrombomodulin is not increased in familial hypercholesterolemic children with rheological alterations.
Vayá A; Martínez M; Dalmau J; Martí R; Ballesta A; Aznar J
Clin Hemorheol Microcirc; 1998 Oct; 19(2):133-8. PubMed ID: 9849926
[TBL] [Abstract][Full Text] [Related]
5. [The erythrocyte membrane structure in patients with mixed hyperlipidemia].
Broncel M; Balcerak M; Bała A; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(1-2):4-9. PubMed ID: 17607961
[TBL] [Abstract][Full Text] [Related]
6. Alterations of erythrocyte lipid pattern and of some membrane related functions as a consequence of plasma lipid disorder in diabetes mellitus.
Cignarelli M; Blonda M; Cospite MR; Damato A; Nardelli G; Giorgino R
Diabete Metab; 1983 Dec; 9(4):272-6. PubMed ID: 6667763
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte membrane composition in patients with primary hypercholesterolemia.
Vayá A; Martínez Triguero M; Réganon E; Vila V; Martínez Sales V; Solá E; Hernández Mijares A; Ricart A
Clin Hemorheol Microcirc; 2008; 40(4):289-94. PubMed ID: 19126991
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte membrane, plasma and atherosclerotic plaque lipid pattern in coronary heart disease.
Lausada NR; Boullón S; Boullón F; Tacconi de Gómez Dumm IN
Medicina (B Aires); 2007; 67(5):451-7. PubMed ID: 18051228
[TBL] [Abstract][Full Text] [Related]
9. Changes of plasma lipids and erythrocyte membrane fluidity in psoriatic children.
Ferretti G; Simonetti O; Offidani AM; Messini L; Cinti B; Marshiseppe I; Bossi G; Curatola G
Pediatr Res; 1993 May; 33(5):506-9. PubMed ID: 8511025
[TBL] [Abstract][Full Text] [Related]
10. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J
Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164
[TBL] [Abstract][Full Text] [Related]
11. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
12. Alteration of plasma and erythrocyte membrane lipid components in hyperthyroid rats.
Ruggiero FM; Landriscina C; Gnoni GV; Quagliariello E
Horm Metab Res; 1984 Jan; 16(1):37-40. PubMed ID: 6698491
[TBL] [Abstract][Full Text] [Related]
13. [The comparison in vitro the effects of pravastatin and quercetin on the selected structural parameters of membrane erythrocytes from patients with hypercholesterolemia].
Broncel M; Franiak I; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2007 Feb; 22(128):112-6. PubMed ID: 17598654
[TBL] [Abstract][Full Text] [Related]
14. Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia.
Martinez M; Vaya A; Marti R; Gil L; Lluch I; Carmena R; Aznar J
Haemostasis; 1996 Oct; 26 Suppl 4():171-6. PubMed ID: 8979121
[TBL] [Abstract][Full Text] [Related]
15. [Changes of erythrocyte and lymphocyte membrane fluidity after plasma extraction in children with type II homozygous hypercholesterolemia].
Motta C; Palcoux JB; Meyer M; Roche M
Ann Med Interne (Paris); 1988; 139 Suppl 1():83-5. PubMed ID: 3247997
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition.
Calişkan S; Calişkan M; Kuralay F; Onvural B
Res Exp Med (Berl); 2000 Feb; 199(4):189-94. PubMed ID: 10743676
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C.
Tanaka H; Miyano M; Ueda H; Fukui K; Ichinose M
Clin Exp Med; 2005 Dec; 5(4):190-5. PubMed ID: 16362799
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte lipid alterations in pediatric cholestatic liver disease: relationship to serum bile acids.
Cynamon HA; Isenberg JN
Hepatogastroenterology; 1986 Jun; 33(3):98-100. PubMed ID: 3744283
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte and plasma lipids in liver diseases.
Agbedana EO; Ariyo JO; Olubuyide IO; Taylor GO
Mater Med Pol; 1991; 23(2):117-20. PubMed ID: 1842597
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte deformability in young familial hypercholesterolemics.
Vayá A; Martínez M; Guillén M; Dalmau J; Aznar J
Clin Hemorheol Microcirc; 1998 Sep; 19(1):43-8. PubMed ID: 9806733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
